New pill offers hope for taming the Flare-Ups of lupus
NCT ID NCT07311200
Summary
This study is testing an experimental pill called D-2570 to see if it can help control the disease activity in people with active systemic lupus erythematosus (SLE). About 120 participants will be randomly assigned to take either the new drug or a placebo pill once a day for nearly a year. The main goal is to see if the drug is effective at reducing lupus symptoms and flares and to check how safe it is for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.